536565 (2)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE lists 4,00,000 new equity shares of Novelix Pharmaceuticals Limited issued on a preferential basis pursuant to conversion of warrants, … | |||||||||||||||
BSE lists 4,00,000 new equity shares of Novelix Pharmaceuticals Limited issued on a preferential basis pursuant to conversion of warrants, effective March 9, 2026.
| |||||||||||||||
BSE announces listing and trading permission for 4,00,000 new equity shares of Novelix Pharmaceuticals Limited effective March 9, 2026, … | |||||||||||||||
BSE announces listing and trading permission for 4,00,000 new equity shares of Novelix Pharmaceuticals Limited effective March 9, 2026, issued on a preferential basis pursuant to conversion of warrants.
| |||||||||||||||